These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33481813)

  • 1. Role and effects of zinc supplementation in HIV-infected patients with immunovirological discordance: A randomized, double blind, case control study.
    Silva M; Montes CG; Canals A; Mackenna MJ; Wolff M
    PLoS One; 2021; 16(1):e0244823. PubMed ID: 33481813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunovirological discordance among female sex workers who start antiretroviral therapy in Burkina Faso.
    Bazié WW; Somé DY; Traoré IT; Sanon A; Konaté I; Tassembedo S; Taofiki AO; Kania D; Ouédraogo A; Vuylsteke B; Gilbert C; Meda N; Ouédraogo AS; Nagot N
    BMC Infect Dis; 2022 Feb; 22(1):117. PubMed ID: 35114959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Zinc Supplementation vs Placebo on Mortality Risk and HIV Disease Progression Among HIV-Positive Adults With Heavy Alcohol Use: A Randomized Clinical Trial.
    Freiberg MS; Cheng DM; Gnatienko N; Blokhina E; Coleman SM; Doyle MF; Yaroslavtseva T; Bridden C; So-Armah K; Tracy R; Bryant K; Lioznov D; Krupitsky E; Samet JH
    JAMA Netw Open; 2020 May; 3(5):e204330. PubMed ID: 32383748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count.
    García F; de Lazzari E; Plana M; Castro P; Mestre G; Nomdedeu M; Fumero E; Martínez E; Mallolas J; Blanco JL; Miró JM; Pumarola T; Gallart T; Gatell JM
    J Acquir Immune Defic Syndr; 2004 Jun; 36(2):702-13. PubMed ID: 15167289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic effect of zinc supplementation in HIV-infected children receiving highly active antiretroviral therapy: a randomized, double-blind, placebo-controlled trial.
    Lodha R; Shah N; Mohari N; Mukherjee A; Vajpayee M; Singh R; Singla M; Saini S; Bhatnagar S; Kabra SK
    J Acquir Immune Defic Syndr; 2014 Aug; 66(4):386-92. PubMed ID: 24798767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, controlled clinical trial of zinc supplementation to prevent immunological failure in HIV-infected adults.
    Baum MK; Lai S; Sales S; Page JB; Campa A
    Clin Infect Dis; 2010 Jun; 50(12):1653-60. PubMed ID: 20455705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with immunological and virological discordant responses to highly active antiretroviral therapy among adult HIV positive individuals in Ethiopia: A cross-sectional study.
    Manaye GA; Abateneh DD; Asmare WN; Abebe M
    Medicine (Baltimore); 2021 Nov; 100(47):e27624. PubMed ID: 34964727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low plasma zinc levels and immunological responses to zinc supplementation in HIV-infected patients with immunological discordance after antiretroviral therapy.
    Asdamongkol N; Phanachet P; Sungkanuparph S
    Jpn J Infect Dis; 2013; 66(6):469-74. PubMed ID: 24270132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of zinc supplementation for children with HIV-1 infection in South Africa: a randomised double-blind placebo-controlled trial.
    Bobat R; Coovadia H; Stephen C; Naidoo KL; McKerrow N; Black RE; Moss WJ
    Lancet; 2005 Nov; 366(9500):1862-7. PubMed ID: 16310552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micronutrient supplementation in adults with HIV infection.
    Visser ME; Durao S; Sinclair D; Irlam JH; Siegfried N
    Cochrane Database Syst Rev; 2017 May; 5(5):CD003650. PubMed ID: 28518221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV treatment outcomes following antiretroviral therapy initiation and monitoring: A workplace program in Papua, Indonesia.
    Limmade Y; Fransisca L; Rodriguez-Fernandez R; Bangs MJ; Rothe C
    PLoS One; 2019; 14(2):e0212432. PubMed ID: 30802257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
    Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y
    J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+ cell count recovery after initiation of antiretroviral therapy in HIV-infected Ethiopian adults.
    Fiseha T; Ebrahim H; Ebrahim E; Gebreweld A
    PLoS One; 2022; 17(3):e0265740. PubMed ID: 35324948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Structured therapeutic interruption in patients infected with HIV-1 experiencing a block in their antiretroviral treatment: preliminary results].
    Rey D; Schmitt MP; Hess-Kempf G; Krantz V; Partisani M; Bernard-Henry C; Lang JM
    Pathol Biol (Paris); 2001 Sep; 49(7):559-66. PubMed ID: 11642019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, immunological and virological evolution in patients with CD4 T-cell count above 500/mm3: is there a benefit to treat with highly active antiretroviral therapy (HAART)?
    Piroth L; Binquet C; Buisson M; Kohli E; Duong M; Grappin M; Abrahamowicz M; Quantin C; Portier H; Chavanet P
    Eur J Epidemiol; 2004; 19(6):597-604. PubMed ID: 15330134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delay in cART initiation results in persistent immune dysregulation and poor recovery of T-cell phenotype despite a decade of successful HIV suppression.
    Ndumbi P; Falutz J; Pant Pai N; Tsoukas CM
    PLoS One; 2014; 9(4):e94018. PubMed ID: 24710051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordant Treatment Responses to Combination Antiretroviral Therapy in Rwanda: A Prospective Cohort Study.
    Kayigamba FR; Franke MF; Bakker MI; Rodriguez CA; Bagiruwigize E; Wit FW; Rich ML; Schim van der Loeff MF
    PLoS One; 2016; 11(7):e0159446. PubMed ID: 27438000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brief Report: Polymorphisms in TNF-α/TNFR1 Pathway Genes Are Associated With CD4+ T-Cell Recovery in HIV-1-Infected Individuals on Antiretroviral Therapy.
    Celerino da Silva R; Alves NMP; Gondim Silva ML; Agrelli A; Coelho AVC; Guimarães RL; Arraes LC; Crovella S; Brandão LAC
    J Acquir Immune Defic Syndr; 2021 Nov; 88(3):322-327. PubMed ID: 34267056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa.
    Okomo U; Togun T; Oko F; Peterson K; Townend J; Peterson I; Jaye A
    BMC Pediatr; 2012 Jul; 12():95. PubMed ID: 22770231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.